Letters
Lipid lowering drugs in diabetes: Lipid lowering has ophthalmic benefits
BMJ 2006; 332 doi: https://doi.org/10.1136/bmj.332.7552.1272-b (Published 25 May 2006) Cite this as: BMJ 2006;332:1272
- Hiten G Sheth, specialist registrar (drhitensheth@yahoo.co.uk),
- Sher Aslam, senior house officer,
- Nigel Davies, consultant
- Department of Ophthalmology, Chelsea and Westminster Hospital, London SW10 9NH
- Department of Ophthalmology, Chelsea and Westminster Hospital, London SW10 9NH
EDITOR—Lipid lowering treatment in diabetes has ophthalmic benefits.1 Diabetic maculopathy is a common cause of loss of sight in diabetic patients and is characterised by retinal oedema and lipid exudates. The use of atorvastatin in diabetic maculopathy has recently been shown in a randomised controlled trial to decrease visible lipid exudates and …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.